Health Robotics Canada Quickly Becomes Largest American I.V. Robotics Company with 15 Contracts in First 3 Months

BOZEN, Sud-Tirol, Italy, April 19, 2010 - Health Robotics today announced the outstanding results reported by one
of its American partners, Health Robotics Canada Inc. (HRCI) first trimester
of operations since its inception in December 2009. These impressive results
included new contracts in North America for seven i.v.STATION, six i.v.SOFT,
one CytoCare, and one I.V. Room of the Future, quickly eclipsing in its first
three months of existence all the other I.V. Automation companies that have
been present in the field of North American I.V. Robotics for the past 22
years, including IHS/RIVA[1].

"HRCI had an outstanding first quarter of operations, quickly
establishing itself as the leader in the North American I.V. Automation
sector, including an agreement with CHUM to pioneer the 1st viable I.V. Robot
installation in Canada in July. Notably, HRCI also signed a joint-development
agreement with The Cleveland Clinic Foundation for the first I.V. Room of the
Future project in America. For a European that graduated from a Clinical
Engineering school in the United States where I came to share cross-atlantic
biomedical engineering experiences many years ago, thanks to HRCI it is
indeed a great honor to return and partner with top-rated medical
institutions in America, with the clear goal to develop global centers of
excellence for the I.V. Room of the Future, not only with Health Robotics'
world-leading products, but also with best-in-class I.V. solutions from
companies selected by us to participate in this project" stated Werner
Rainer, Health Robotics' CEO.

Our joint-venture partner HRCI also reported to Health Robotics contracts
for installations of seven Health Robotics' i.v.STATION robots at Allegiance
Health (Jackson, Michigan), The Brigham & Women's Hospital (Boston), U Mass
Memorial Hospital (Worcester), [these first 3 already installed by HRCI],
Centre Hospitalier de l'Universite de Montreal [CHUM], Cottage Health System
(Santa Barbara), The University of Colorado Hospital (Denver), and The
University of Texas M.D. Anderson Cancer Center (Houston).

Additionally, HRCI reported signing 6 contracts for Beta Test/Validation
installations of i.v.SOFT Assist, Cube, Label+, and Profile workflow software
automation modules at The Brigham & Women's Hospital in Boston, The Cleveland
Clinic Foundation, Duke University Hospital in Durham, Princess Margaret
Hospital in Toronto, The University of Chicago Medical Center, and The
University of Texas M.D. Anderson Cancer Center in Houston.

Finally, several months after terminating its contract with Devon
Robotics, the University of Colorado Hospital signed an agreement with HRCI
[subsequently assigned to McKesson Automation, Health Robotics' exclusive
North American partner for CytoCare] in order to upgrade to a new and
improved version of CytoCare in May 2010.

"As we quickly approach 100 global installations for our solutions, I'm
glad to see that Health Robotics' first ever customer in America has
recommitted itself to CytoCare, the only robot in the world proven to
compound sterile hazardous I.V. Admixtures. Despite unfounded rumors
maliciously spread by our competitors and our prior distributors that the new
partnerships with McKesson and HRCI would signify the demise of Health
Robotics in North America, to the contrary: HRCI's reported number and
quality of contracts clearly show that HRCI quickly stepped-up to the plate
signing 15 contracts in only 3 months, and beating IHS/RIVA to the 1st I.V.
Robotics installation in IHS' home country of Canada [compared with no sales
by Devon in the 15 months preceding HRCI's start], while McKesson has swiftly
moved to provide responsive CytoCare customer support and is now poised to
make significant gains in the market," concluded Mr. Rainer.

About Health Robotics:

Health Robotics is the undisputed global leading supplier of
life-critical intra-venous medication robots, providing healthcare facilities
in 5 continents with robotics technology and software automation solutions
deployed utilizing virtual high-availability technology. Its world-leading
solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs],
i.v.SOFT(TM) [workflow engine for manual compounding, powered by
MEDarchiver], and TPNstation(TM) [totally-automated parenteral nutrition]
have and will greatly contribute to ease hospitals' growing pressures to
improve patient safety, increase throughput and contain costs. Through the
effective and efficient production of sterile, accurate, tamper-evident and
ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate
life-threatening drug-exchange errors, decrease other therapy oversights and
sterility risks, work more efficiently, reduce waste and controlled
substances' diversion, and diminish the gap between rising patient
volume/acuity and scarce nursing and pharmacy staff. For more information,
please visit www.health-robotics.com

    For additional information, please contact:

    Health Robotics S.r.l.
    Claudia Flaim
    Marketing Coordinator
    Italy: +39-0471-200-372
    flaim@health-robotics.com

    ---------------------------------

    [1] Am J Hosp Pharm 46(11): 2286-93 1989

For additional information, please contact: Health Robotics S.r.l., Claudia Flaim, Marketing Coordinator, Italy: +39-0471-200-372, flaim at health-robotics.com